Promote sustainable fat reduction (more than a short-term benefit)
This helps your body adjust to the medication and reduces the likelihood of side effects
Table of Contents Understanding GLP1 Obesity Treatment Clinical Evidence and Impact on Diabetes Practical Considerations for LongTerm Use Patient Counseling and Shared Decisions Conclusion Frequently Asked Questions Understanding GLP1 Obesity Treatment GLP1 receptor agonists (GLP1 RAs) have gained attention for their dual benefits in glycemic control and weight reduction
Clin Neurosci Res 6:261281 Lee M, Cho T, Jantaratnotai N, Wang YT, McGeer E, McGeer PL (2010) Depletion of GSH in glial cells induces neurotoxicity: relevance to aging and degenerative neurological diseases
By comparison, Wegovys standard data comes from 68-week trials where weight loss had largely leveled off
These symptoms frequently manifest during the initial treatment phase, affecting approximately 50% to 60% of patients [8], but they generally diminish over time, with their occurrence being dose-dependent